Key Client Fiduciary Advisors »

Mymd Pharmaceuticals shares owned by Key Client Fiduciary Advisors

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by Key Client Fiduciary Advisors from 13F filings

Historical chart of Key Client Fiduciary Advisors investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Key Client Fiduciary Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $2.5k 20k 0.12
2025-03-31 $7.0k 20k 0.35

More positions owned by Key Client Fiduciary Advisors

Galaxy Digital Cl A (GLXY)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Indxx Aerospace (MISL)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
First Tr Exchange-traded SHS (FDL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Putnam Etf Trust Focused Lar Cap (PVAL)
First Tr Exchange-traded Smid Risng Etf (SDVY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Growth Strength (FTGS)
Annaly Capital Management In Com New (NLY)

View all positions for Key Client Fiduciary Advisors

Top funds holding Mymd Pharmaceuticals

Advisor Group Holdings

View all funds holding Mymd Pharmaceuticals